Profile
| Metric | Value |
|---|---|
| Full Name | Nautilus Biotechnology, Inc. |
| Ticker | NASDAQ: NAUT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | nautilus.bio |
| Employees | 134 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.03 | ||
| Price, 1D Change | +0.50% | |
| $256M | ||
| - | ||
| - | ||
| 1.79 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.56 | ||
| EPS, 1Y Change | -10.71% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | ARYA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.56 | ||
| EPS Estimate | -$0.53 | |
| EPS Est. Change | +6.96% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $2.03 | ||
| Price Target | - | $2.50 |
| Price Tgt. Change | - | +23.15% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.56 | -$0.51 | +8.98% | |
| -$0.62 | -$0.56 | +8.24% | |
| -$0.53 | N/A | +6.96% | |
| -$0.61 | N/A | -8.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $1.50M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +19.41% | ||
| +0.50% | ||
| +19.60% | ||
| +1.65% | ||
| 0.00% | ||
| 0.00% | ||
| -10.71% | ||
| +5.27% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.03 | ||
| $1.19 | ||
| SMA 200 vs Price | -41.40% | |
| $2.02 | ||
| SMA 50 vs Price | -0.61% | |
| 1.79 | ||
| $0.16 | ||
| 50.41 | ||
| 85.50% | ||
| 105.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.56 | ||
| -$6.35M | ||
| - | ||
| -$81.48M | ||
| - | ||
| -$70.78M | ||
| - | ||
| -$75.12M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.15 | ||
| 17.40 | ||
| 17.40 | ||
| - | ||
| - | ||
| 2.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.52 | ||
| -2.53 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $208.73M | ||
| $27.65M | ||
| $242.74M | ||
| $132.83M | ||
| $34.01M | ||
| $7.63M | ||
| $30.48M | ||
| $4.10M | ||
| $987.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $81.48M | ||
| $81.48M | ||
| $6.35M | ||
| $31.00M | ||
| $6.35M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$59.15M | ||
| $66.25M | ||
| $1.14M | ||
| $2.12M | ||
| -$61.27M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Goldman Sachs | → | |
| Guggenheim | ||
| Morgan Stanley | → | |
| Morgan Stanley | ||
| Goldman Sachs | ||
| Goldman Sachs | ||
| Goldman Sachs | ||
| Morgan Stanley | ||
| Cowen & Co. | ||
| Goldman Sachs |
Analyst sentiment
Institutional ownership
Screeners with NAUT
FAQ
What is the ticker symbol for Nautilus Biotechnology, Inc.?
The ticker symbol for Nautilus Biotechnology, Inc. is NASDAQ:NAUT
Does Nautilus Biotechnology, Inc. pay dividends?
No, Nautilus Biotechnology, Inc. does not pay dividends
What sector is Nautilus Biotechnology, Inc. in?
Nautilus Biotechnology, Inc. is in the Healthcare sector
What industry is Nautilus Biotechnology, Inc. in?
Nautilus Biotechnology, Inc. is in the Biotechnology industry
What country is Nautilus Biotechnology, Inc. based in?
Nautilus Biotechnology, Inc. is headquartered in United States
When did Nautilus Biotechnology, Inc. go public?
Nautilus Biotechnology, Inc. initial public offering (IPO) was on August 7, 2020
Is Nautilus Biotechnology, Inc. in the S&P 500?
No, Nautilus Biotechnology, Inc. is not included in the S&P 500 index
Is Nautilus Biotechnology, Inc. in the NASDAQ 100?
No, Nautilus Biotechnology, Inc. is not included in the NASDAQ 100 index
Is Nautilus Biotechnology, Inc. in the Dow Jones?
No, Nautilus Biotechnology, Inc. is not included in the Dow Jones index
When was Nautilus Biotechnology, Inc. last earnings report?
Nautilus Biotechnology, Inc.'s most recent earnings report was on October 28, 2025
When does Nautilus Biotechnology, Inc. report earnings?
The next expected earnings date for Nautilus Biotechnology, Inc. is February 26, 2026
Data Sources & References
- NAUT Official Website www.nautilus.bio
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1808805/000180880525000080/0001808805-25-000080-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1808805/000180880525000008/0001808805-25-000008-index.htm
- NAUT Profile on Yahoo Finance finance.yahoo.com/quote/NAUT
- NAUT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/naut